NASDAQ:ALLR

Allarity Therapeutics Stock Predictions

etoro logo Buy ALLR
*Your capital is at risk
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLR Prediction Chart

ALLR Predictions History

Latest community submissions for ALLR.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 14, 2025 Bullish $0.98 X 0
Jan 14, 2025 $1.00 -6.38% $1.01 V 99.18% 3
Jan 14, 2025 $1.03 -3.99% $1.01 V 98.28% 1
Jan 14, 2025 Bearish $1.01 V 1
Jan 13, 2025 $0.97 -6.67% $1.07 X 90.71% 0
Jan 13, 2025 $1.08 +4.17% $1.07 V 98.75% 2
Jan 13, 2025 Bearish $1.07 X 0
Jun 3, 2024 $0.531 -97.13% $0.610 V 87.08% 1
Jun 3, 2024 $0.563 -96.95% $0.610 V 92.30% 1
Rybkarybka Rybkarybka Merchant
Jun 3, 2024 $0.80 -95.40% $0.610 X 68.83% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLARITY THERAPEUTICS, INC.
Allarity Therapeutics
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE